Enveric Biosciences Inc vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while YieldMax NVDA Option Income Strategy ETF trades at $12.54. Which is the better fit depends on your goals.
| ENVB | NVDY | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $17.40 | $17.96 |
52-Week Low | $1.28 | $12.03 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDY (YieldMax NVDA Option Income Strategy ETF) trades at $12.52, down 2.19% today, with a bullish technical signal despite bearish moving averages. The fund generates weekly dividend income through options strategies on NVIDIA stock, with recent distributions ranging from $0.10 to $0.21 per share. Technical indicators show mixed signals with RSI in neutral territory and key support at $12.
The ETF offers high income potential but sacrifices NVIDIA's upside gains, creating an opportunity cost trade-off. Risks include dependence on NVIDIA's volatility for option premiums and underperformance during strong NVIDIA rallies. Investors seeking consistent income may find value, while those wanting NVIDIA's full growth potential should consider direct exposure.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →